These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8959030)
1. Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system. Miller DB; O'Callaghan JP Ann N Y Acad Sci; 1996 Oct; 801():148-67. PubMed ID: 8959030 [TBL] [Abstract][Full Text] [Related]
2. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Miller DB; O'Callaghan JP Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961 [TBL] [Abstract][Full Text] [Related]
3. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. Miller DB; O'Callaghan JP J Pharmacol Exp Ther; 1994 Aug; 270(2):752-60. PubMed ID: 8071868 [TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. O'Callaghan JP; Miller DB J Pharmacol Exp Ther; 1994 Aug; 270(2):741-51. PubMed ID: 8071867 [TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse. Johnson EA; O'Callaghan JP; Miller DB Brain Res; 2002 Apr; 933(2):130-8. PubMed ID: 11931857 [TBL] [Abstract][Full Text] [Related]
6. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Miller DB; O'Callaghan JP; Ali SF Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321 [TBL] [Abstract][Full Text] [Related]
7. Restraint as a stressor in mice: against the dopaminergic neurotoxicity of D-MDMA, low body weight mitigates restraint-induced hypothermia and consequent neuroprotection. Johnson EA; Sharp DS; Miller DB Brain Res; 2000 Sep; 875(1-2):107-18. PubMed ID: 10967304 [TBL] [Abstract][Full Text] [Related]
8. Brain concentrations of d-MDMA are increased after stress. Johnson EA; O'Callaghan JP; Miller DB Psychopharmacology (Berl); 2004 May; 173(3-4):278-86. PubMed ID: 14735292 [TBL] [Abstract][Full Text] [Related]
9. Effects of prenatal ethanol exposure on hypothalamic-pituitary-adrenal regulation after adrenalectomy and corticosterone replacement. Glavas MM; Hofmann CE; Yu WK; Weinberg J Alcohol Clin Exp Res; 2001 Jun; 25(6):890-7. PubMed ID: 11410726 [TBL] [Abstract][Full Text] [Related]
10. Variations in corticosterone feedback do not reveal differences in hpa activity after prenatal ethanol exposure. Gabriel KI; Ellis L; Yu W; Weinberg J Alcohol Clin Exp Res; 2001 Jun; 25(6):907-15. PubMed ID: 11410728 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698 [TBL] [Abstract][Full Text] [Related]
12. Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels--a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Dhabhar FS; McEwen BS; Spencer RL Brain Res; 1993 Jul; 616(1-2):89-98. PubMed ID: 8395308 [TBL] [Abstract][Full Text] [Related]
13. Strain differences in hypothalamic pituitary adrenocortical axis function and adipogenic effects of corticosterone in rats. Marissal-Arvy N; Gaumont A; Langlois A; Dabertrand F; Bouchecareilh M; Tridon C; Mormede P J Endocrinol; 2007 Dec; 195(3):473-84. PubMed ID: 18000309 [TBL] [Abstract][Full Text] [Related]
14. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Makino S; Smith MA; Gold PW Brain Res; 2002 Jul; 943(2):216-23. PubMed ID: 12101044 [TBL] [Abstract][Full Text] [Related]
15. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. Itzhak Y; Gandia C; Huang PL; Ali SF J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865 [TBL] [Abstract][Full Text] [Related]
16. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. Albers DS; Sonsalla PK J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070 [TBL] [Abstract][Full Text] [Related]
18. Role of the dorsomedial hypothalamus in glucocorticoid-mediated feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stamper CE; Hennessey PA; Hale MW; Lukkes JL; Donner NC; Lowe KR; Paul ED; Spencer RL; Renner KJ; Orchinik M; Lowry CA Stress; 2015 Jan; 18(1):76-87. PubMed ID: 25556980 [TBL] [Abstract][Full Text] [Related]
19. Protracted exposure to supraphysiological levels of corticosterone does not cause neuronal loss or damage and protects against kainic acid-induced neurotoxicity in the hippocampus of C57BL/6J mice. Benkovic SA; O'Callaghan JP; Miller DB Neurotoxicology; 2009 Nov; 30(6):965-76. PubMed ID: 19616023 [TBL] [Abstract][Full Text] [Related]
20. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]